I.V.F. patients are faced with a growing list of costly “add-ons.” For one such test, some say more robust research is needed to support its effectiveness.
Published: December 18, 2021 at 11:00AM
from NYT Health https://ift.tt/3Fg177e
I.V.F. patients are faced with a growing list of costly “add-ons.” For one such test, some say more robust research is needed to support its effectiveness.
Published: December 18, 2021 at 11:00AM
from NYT Health https://ift.tt/3Fg177e